Viriom Secures $4,700,000 New Financing Round

  • Feed Type
  • Date
    5/13/2016
  • Company Name
    Viriom
  • Mailing Address
    6605 Nancy Ridge Drive San Diego, CA 92121 USA
  • Company Description
    Viriom Inc. is a late-stage biotech company developing novel and affordable therapies against life threatening infections such as HIV (human immunodeficiency virus). The company has an exclusive worldwide license to its Phase 2/3 stage drug Elpida® and other drug candidates from Hoffmann-La Roche for HIV.
  • Website
    http://www.viriom.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,700,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed